The New York Times – Business:
In Washington, China hawks say its economy is too weak to withstand a tariff shock. In the city of Yiwu, factories are showing why, for now, that may be a miscalculation.
The New York Times – Business:
In Washington, China hawks say its economy is too weak to withstand a tariff shock. In the city of Yiwu, factories are showing why, for now, that may be a miscalculation.
The New York Times – Business:
An interview with a 26-year-old entrepreneur, who has taken seven trips to China to buy handbags, clothes and jewelry. “China is the center of everything,” she said.
The New York Times – Business:
Blue Origin, owned by Jeff Bezos, and Lockheed Martin are among the contractors that may compete with Elon Musk’s company in the race back to the lunar surface.
The New York Times – Business:
President Trump’s plan to import red meat runs counter to his philosophy of increasing domestic production, and has angered cattle ranchers in the United States.
The New York Times – Business:
Roughly three million Americans canceled the streaming service in the month that it temporarily suspended Jimmy Kimmel’s show. About 4.1 million people canceled Disney-owned Hulu.
The New York Times – Business:
The revival of America’s industrial base is happening amid pine forests and peanut farms. And it’s being led by a South Korean company.
The New York Times – Business:
ICE and other law enforcement agencies detained nearly 500 workers in Georgia in September. Farah Stockman, who covers manufacturing for The New York Times, describes the fallout from the incident and what could be next for foreign factory investments in the U.S.
The New York Times – Business:
Extending subsidies for the Affordable Care Act has emerged as a major sticking point in Washington, and could carry the biggest economic consequences.
The New York Times – Business:
The ticketing company is already a significant player in the two big theater markets of New York and London.
The New York Times – Business:
The three-year-old artificial intelligence start-up has drawn investor attention, and money, as its use among doctors, nurses and others skyrockets.